Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 280 | 867 | 136 | 2,830 | 2,503 |
| Gross Profit | 280 | 867 | 136 | 2,830 | 2,503 |
| Operating Expenses | 30,701 | 24,819 | 28,336 | 31,365 | 32,002 |
| Operating Income | -30,421 | -23,952 | -28,201 | -28,535 | -29,499 |
| Interest Expense | 2,669 | 2,429 | 2,195 | 656 | 0 |
| Other Income | -5,145 | 2,844 | 710 | -161 | -3,463 |
| Pre-tax Income | -38,235 | -23,537 | -29,686 | -29,352 | -32,962 |
| Income Tax | -88 | N/A | -107 | -63 | N/A |
| Net Income Continuous | -38,147 | -23,537 | -29,579 | -29,289 | -32,962 |
| Minority Interests | -485 | -446 | -192 | -70 | N/A |
| Net Income | $-37,662 | $-23,091 | $-29,387 | $-29,219 | $-32,962 |
| EPS Basic Total Ops | -4.56 | -2.76 | -3.60 | -3.60 | -4.20 |
| EPS Basic Continuous Ops | -4.58 | -2.85 | -3.62 | -3.61 | -4.16 |
| EPS Diluted Total Ops | -4.32 | -3.00 | -3.60 | -3.60 | -4.08 |
| EPS Diluted Continuous Ops | -4.68 | -2.75 | -3.62 | -3.61 | -4.16 |
| EBITDA(a) | $-28,451 | $-22,802 | $-27,002 | $-27,336 | $-28,253 |